Influence of apolipoprotein E varepsilon4 on rates of cognitive and functional decline in mild cognitive impairment - Wikidata - awgldk - TriplyDB

Influence of apolipoprotein E varepsilon4 on rates of cognitive and functional decline in mild cognitive impairment

Influence of apolipoprotein E varepsilon4 on rates of cognitive and functional decline in mild cognitive impairment

http://www.wikidata.org/entity/Q34147612

about

Vitamin E for Alzheimer's dementia and mild cognitive impairment Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy The apolipoprotein e antagonistic pleiotropy hypothesis: review and recommendations Adverse Effects of the Apolipoprotein E ε4 Allele on Episodic Memory, Task Switching and Gray Matter Volume in Healthy Young Adults APOE and APOC1 gene polymorphisms are associated with cognitive impairment progression in Chinese patients with late-onset Alzheimer's disease.Comparing measures of decline to dementia in amnestic MCI subjects in the National Alzheimer's Coordinating Center (NACC) Uniform Data Set The relationship between regional brain volumes and the extent of coronary artery disease in mild cognitive impairment Vitamin E for Alzheimer's dementia and mild cognitive impairment.Evaluating the cognitive effects of donepezil 23 mg/d in moderate and severe Alzheimer's disease: analysis of effects of baseline features on treatment response.Cognitive function and gait speed under normal and dual-task walking among older adults with mild cognitive impairment Genetic Risk Score Predicts Late-Life Cognitive Impairment.Diagnosing Mild Cognitive Impairment (MCI) in clinical trials: a systematic review.Midlife cardiovascular risk impacts executive function: Framingham offspring study.Gene-environment interaction between lead and Apolipoprotein E4 causes cognitive behavior deficits in mice.Effect of flavonoids on learning, memory and neurocognitive performance: relevance and potential implications for Alzheimer's disease pathophysiology.Phenotypic differences between apolipoprotein E genetic subgroups: research and clinical implications Influence of Apolipoprotein E polymorphism on susceptibility of Wilson disease.Use of the CogState Brief Battery in the assessment of Alzheimer's disease related cognitive impairment in the Australian Imaging, Biomarkers and Lifestyle (AIBL) study.A methodological critique of the National Institute of Aging and Alzheimer's Association Guidelines for Alzheimer's disease, dementia, and mild cognitive impairments.The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog): Modifications and Responsiveness in Pre-Dementia Populations. A Narrative Review.Subgroup analysis of US and non-US patients in a global study of high-dose donepezil (23 mg) in moderate and severe Alzheimer's disease.The Role of ApoE Polymorphism in the Relationship between Serum Steroid Hormone Levels and Cognition in Older Chinese Adults: A Cross-Sectional Study.Impact of Flavonoids on Cellular and Molecular Mechanisms Underlying Age-Related Cognitive Decline and Neurodegeneration.Vitamin E for Alzheimer's dementia and mild cognitive impairment The cholinergic system in the pathophysiology and treatment of Alzheimer's disease Polymorphisms in theSortilin-Related Receptor 1Gene Are Associated with Cognitive Impairment in Filipinos

P2860

Q24202844-AD18A95D-0D85-4684-8CF5-EB6DE6750DB7 Q28282855-7BD791B2-D868-44DB-82B2-F666A3BC87C5 Q28386834-26B6C71D-A733-4B07-BAB6-160A45F1C44A Q33849832-B3263C8D-5EB7-4E9D-861A-2C63203B87E5 Q34096072-5FDD6655-6116-448F-B392-75C298DE0A08 Q34311058-C7200FFC-0C4E-4C15-9242-50D9C3A5583D Q34529816-4B44C74A-AC26-460A-A78E-8970E8231CB6 Q34550138-2224BDDF-872E-4383-B03E-540E53651B4F Q34762064-0CEB15FA-27F9-41FB-AFA1-9D0D1B7F33E3 Q35138055-C6260C74-8F91-4F83-BD99-0636C80076A4 Q36031233-0B2BB1BE-44F5-4CA1-972B-F61A0D1A8BBC Q36650249-901ECFA8-AED8-4C20-84A7-7A58A997CCB5 Q37622163-868E9C7B-9E80-4901-8D02-ACACA962E079 Q37630982-85C86DED-9E6F-4F4B-8FB2-8B60E31F12D3 Q38171400-39B2FDB7-5EDD-4299-8DB0-236E3025D908 Q42355578-EB44281F-92AD-4487-B774-0DE6F60B6FB9 Q47615895-979C0D9C-E2F8-4EE7-95CF-5A26A003C983 Q48756217-513F004B-4C47-45C3-9117-441248DF83BB Q50706594-96867D46-377E-4829-8D05-850BD8624D4B Q52585260-35CA8889-DC2F-4281-A4EE-BB23146773BC Q53332226-B6E3EB33-AF9F-4F46-B037-61BCA57CB461 Q55002052-46CF402D-8A99-4808-9A92-4932BAD68750 Q55007348-452284DD-2A93-463F-B558-4522FCA05285 Q56092262-CED7E48C-5DC7-4C4E-94DD-5D3F6593AEC8 Q57177786-AD6F2153-71C1-431B-B739-CA84478A24AF Q59052204-9EA90B6B-5F75-4BF3-B2BA-F2571C4D8CDE

P2860

Influence of apolipoprotein E varepsilon4 on rates of cognitive and functional decline in mild cognitive impairment

http://www.wikidata.org/entity/Q34147612

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Influence of apolipoprotein E ...... e in mild cognitive impairment

@ast

Influence of apolipoprotein E ...... e in mild cognitive impairment

@en

Influence of apolipoprotein E ...... e in mild cognitive impairment

@nl

type

label

Influence of apolipoprotein E ...... e in mild cognitive impairment

@ast

Influence of apolipoprotein E ...... e in mild cognitive impairment

@en

Influence of apolipoprotein E ...... e in mild cognitive impairment

@nl

prefLabel

Influence of apolipoprotein E ...... e in mild cognitive impairment

@ast

Influence of apolipoprotein E ...... e in mild cognitive impairment

@en

Influence of apolipoprotein E ...... e in mild cognitive impairment

@nl

P1433

Q34147612-6136E491-629D-49F0-A133-C0F6A853EE32

P1476

Q34147612-1A82ED92-AEC8-47CD-A48C-6B54600829EB

P2093

Q34147612-09194A2A-965E-42DE-A54B-67C6B9A963CE

Q34147612-0A004A49-FC4E-4210-BB40-F044F5B15465

Q34147612-1EDB4DCA-F803-436F-ADEC-C6C0C7C3E3A5

Q34147612-76EDD2F6-826D-4EC0-8128-11D9449D3756

Q34147612-77D37C83-9062-42F2-B87A-2FC8FB63D091

Q34147612-9E3D2554-FDD9-479D-B170-3622834E91ED

P2860

Q34147612-06671A9F-391A-43F2-83D8-E935900C74C2

Q34147612-0A7F289C-2CA2-4141-86A1-F7EE5E48D65C

Q34147612-0A80489B-4E07-4E0A-9EEC-C75740BA421B

Q34147612-0BBCCD28-2B6F-4638-85CE-C7F68A703374

Q34147612-12C89E05-028C-4D1F-A028-94CE7E0B9761

Q34147612-167D840C-8D4A-4F50-9708-C0DE9BD7E17E

Q34147612-19DC2913-53C0-4E2E-AF50-EA7A505DA84D

Q34147612-1A1A8C72-195E-4984-9487-7CDC5373EE46

Q34147612-2CE5448F-E4BE-4948-9E64-F7CF27F42588

Q34147612-3A04B384-698D-4CED-B917-1391A1C630D1

P304

Q34147612-B5451DE3-2061-48D8-B868-56DB16C2A927

P31

Q34147612-6B903351-5410-4685-A199-03D1B9E5BFD1

P356

Q34147612-6A0DF66B-84AB-474B-B07C-D88AF921F043

P433

Q34147612-65B111C0-52B6-4D2D-A816-FC31943F7B0D

P478

Q34147612-930A8307-D18C-4C1B-8829-0A75FC248CAE

P50

Q34147612-64364585-6A45-4326-9956-C78871DB13CF

Q34147612-C7991B73-6CE2-43F3-A8A3-76765563CA3A

P577

Q34147612-73E244C2-0E03-4B73-870C-1787E3DC46AD

P5875

Q34147612-CC2E1F8E-BFB3-4948-A697-D9E6BC1B47DF

P698

Q34147612-EB55602A-2B3F-4C69-BF51-3507C8E7EF94

P932

Q34147612-7854BA1A-BF85-4D65-83EE-00E3D2912D7A

P356

J.JALZ.2009.12.003

P1433

Alzheimer's and Dementia

P1476

Influence of apolipoprotein E ...... e in mild cognitive impairment

@en

P2093

Abdullah Sherzai

http://www.w3.org/2001/XMLSchema#string

Adam S Fleisher

http://www.w3.org/2001/XMLSchema#string

Alzheimer's Disease Cooperative Study

http://www.w3.org/2001/XMLSchema#string

Danielle C Whitehair

http://www.w3.org/2001/XMLSchema#string

Jennifer Emond

http://www.w3.org/2001/XMLSchema#string

Rema Raman

http://www.w3.org/2001/XMLSchema#string

P2860

Mild Cognitive Impairment Can Be Distinguished From Alzheimer Disease and Normal Aging for Clinical Trials

“Mini-mental state”

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Mild cognitive impairment: clinical characterization and outcome

The Clinical Dementia Rating (CDR): current version and scoring rules

Mild cognitive impairment: an overview.

Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.

Vitamin E and donepezil for the treatment of mild cognitive impairment.

Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study.

P304

412-419

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JALZ.2009.12.003

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Ronald C. Petersen

P577

2010-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46123833

http://www.w3.org/2001/XMLSchema#string

P698

20813342

http://www.w3.org/2001/XMLSchema#string

P932

2943876

http://www.w3.org/2001/XMLSchema#string